A cosmetic product can be recalled from the European market overnight. This situation is more common than it seems. And contrary to common assumptions, it is not always linked to a defective formula.
To fully understand these challenges, it is essential to revisit the legal definition of a cosmetic product under European regulation.
In most cases, a cosmetic product recall in Europe is caused by regulatory non-compliance. Sometimes seemingly minor, yet sufficient to compromise market access.
The Regulation (EC) No 1223/2009 strictly governs every stage. It is not a final formality, but a structuring framework that shapes product development from the outset.
Understanding this logic means turning a constraint into a driver of safety and performance.
The reality of European cosmetic regulation
European cosmetic regulation is based on a simple principle: ensuring the safety of cosmetic products for the consumer.
A cosmetic product must be safe under normal or reasonably foreseeable conditions of use, in accordance with Regulation (EC) No 1223/2009.
However, in practice, this requirement goes far beyond a theoretical principle. The safety of a cosmetic product can never be assumed.
It must be demonstrated, assessed and documented at every stage of development.
This is precisely where regulatory compliance is determined and where the first errors often arise.
Main causes of cosmetic product non-compliance in Europe
In practice, cases of non-compliance are rarely isolated. They form part of a chain of decisions where every detail matters.
However, certain issues recur regularly during inspections by European authorities.
Safety assessment is a critical point. When incomplete, product compliance is weakened. It is based on three essential elements: ingredients, conditions of use, and the actual user profile, including sensitive skin, children or pregnant women.
An insufficiently substantiated assessment alone may lead to market withdrawal.
The cosmetic product information file (PIF) is another major point of attention. It compiles all data demonstrating the product’s regulatory compliance.
An incomplete, inconsistent or inaccessible PIF remains one of the most frequent causes of non-compliance.
Cosmetic ingredient compliance a major regulatory challenge
Beyond documentation, cosmetic ingredient compliance is strictly regulated in Europe.
The regulation clearly defines prohibited substances, those permitted under conditions, and the applicable usage limits.
At this level, there is no room for interpretation.
The use of a non-compliant ingredient immediately renders the product non-compliant.
In such cases, the consequence is direct: prohibition of market placement or product withdrawal.
Cosmetic manufacturing and quality why GMP are critical
Compliance of a cosmetic product does not rely solely on its formula.
It also depends on the conditions under which it is manufactured.
Good Manufacturing Practices (GMP) govern the entire production process.
It ensures process control, batch reproducibility and consistent product quality over time.
However, in practice, deviations often arise at this stage.
Microbiological contamination, batch variation or process failure may be sufficient to compromise compliance.
In some cases, this leads directly to market withdrawal.
Labelling and cosmetic claims a high-risk area
Labelling and cosmetic claims are strictly regulated in Europe.
Each claim commits the product, the brand and the responsible person.
It must be justified, consistent and supported by robust evidence.
In practice, this is often where discrepancies occur.
An imprecise, exaggerated or insufficiently substantiated claim may be enough to challenge compliance.
Sometimes, everything comes down to a single word.
Why cosmetic claims are often behind product recalls
During inspections, certain non-compliances frequently recur.
Unauthorised ingredient, incomplete product information file (PIF), microbiological contamination or failure to notify the product on the CPNP portal.
However, claims remain a particularly sensitive area.
Governed by Regulation EU no. 655/2013, they must meet specific criteria and be supported by solid evidence, consistent with the formula, the tests performed and the regulatory dossier data.
The slightest inconsistency may trigger non-compliance.
CPNP notification a mandatory step before market placement
Notification on the CPNP portal is mandatory before placing a product on the market, on the European market.
It allows authorities to access essential product information, including composition, labelling and the identity of the responsible person.
Without this declaration, the product cannot be placed on the market.
How to prevent cosmetic product recall
Once on the market, a cosmetic product remains under surveillance.
Authorities may intervene at any time to verify compliance, analyse a product or request access to the product information file.
Depending on the situation, this may lead to corrective actions, withdrawal or recall.
Anticipating these risks from the earliest stages of development remains the most effective strategy.
Cosmetic product control in Europe: understanding market surveillance
In Europe, market surveillance is carried out by the competent authorities of each member state, such as the DGCCRF in France.
Inspections are regular and may occur without prior notice, as part of targeted or random campaigns.
In practice, authorities may sample products directly from the market, analyse their composition, verify labelling and request access to the product information file.
Some inspections follow a report, a consumer complaint or non-compliance identified in another European country.
Authorities may also rely on brand communications, particularly digital content, to verify the consistency of claims.
They also use alert systems such as Safety Gate, enabling rapid information sharing between member states.
Depending on the findings, measures may range from compliance requests to product withdrawal or recall.
A demanding regulation that becomes a competitive advantage
The European regulatory framework is now one of the most stringent in the world.
However, this level of requirement is not only a constraint.
It also represents a powerful lever for credibility and market differentiation.
This explains in part why many brands choose to develop and manufacture their products in Europe, particularly in France.
Beyond regulation, they also seek recognised expertise in cosmetic and dermocosmetic formulation.
A product developed in this context benefits from a high level of trust, including internationally.
Securing your cosmetic products to improve performance
Compliance is built long before placing a product on the market.
It relies on a global approach capable of aligning regulation, formulation, manufacturing and marketing.
When integrated from the earliest stages of development, it is no longer just a constraint, but a true driver of sustainable performance.
This is where the difference is made.
Choosing the right partner therefore becomes a strategic decision.
Laboratoire Orescience supports brands at every stage, combining regulatory expertise, scientific rigour and full control of manufacturing challenges, in Europe and internationally.
